S.1803 - MEDS Act115th Congress (2017-2018)
|Sponsor:||Sen. Hatch, Orrin G. [R-UT] (Introduced 09/13/2017)|
|Committees:||Senate - Judiciary|
|Latest Action:||09/13/2017 Read twice and referred to the Committee on the Judiciary. (Sponsor introductory remarks on measure: CR S5483-5484) (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Summary: S.1803 — 115th Congress (2017-2018)All Information (Except Text)
Introduced in Senate (09/13/2017)
Marijuana Effective Drug Studies Act of 2017 or the MEDS Act
This bill amends the Controlled Substances Act to establish a new, separate registration process to facilitate research involving marijuana and the commercial production of drugs made from marijuana.
Specifically, the bill requires the Drug Enforcement Administration to register manufacturers and distributors to supply marijuana: (1) for use in research, and (2) for the commercial production of approved drugs containing or derived from marijuana.